WGS
GeneDx Holdings Corp.
67.70$
-1.2%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +7.7% | +8.7% | +13.0% | +9.0% | +24.4% | -8.9% | +17.9% | +13.7% | +3.6% | -15.5% | +11.9% | – | |
| – | -4.9% | -6.2% | +10.2% | +5.4% | +1.3% | -2.7% | +11.0% | +1.3% | +30.6% | -19.1% | +6.3% | – | |
| – | +21.8% | +21.6% | +14.8% | +11.4% | +38.4% | -11.7% | +21.2% | +19.2% | -6.6% | -13.6% | +14.7% | – | |
| – | -14.3% | -5.6% | -7.6% | +9.1% | -0.7% | +8.5% | +18.2% | +33.3% | +21.2% | -17.6% | -0.7% | – | |
| – | +2.0% | -12.0% | +9.2% | +2.3% | +4.6% | +17.5% | -16.2% | +62.2% | +8.3% | +57.7% | -2.5% | – | |
| – | -17.3% | -9.4% | +4.8% | +3.9% | +3.2% | +9.8% | -1.7% | +41.7% | +5.5% | +1.9% | +1.4% | – | |
| – | – | – | – | – | – | -151.7% | – | -136.3% | – | – | – | – | |
| – | – | -39.0% | +49.7% | -5.7% | -17.2% | -8.3% | +27.7% | -31.2% | -7.5% | +37.9% | +65.3% | – | |
| – | – | – | – | – | – | -212.3% | – | -169.9% | – | – | – | – | |
| – | – | – | – | – | – | – | -155.0% | – | -328.3% | – | -42.3% | – | |
| – | – | – | – | – | – | -220.1% | – | -170.6% | – | – | – | – | |
| – | – | – | – | – | – | -98.0% | +7,345.3% | -102.0% | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.